TITLE

Early HIV infection: to treat or not to treat?

AUTHOR(S)
Stewart, Ann Marie; Weller, Ian; Darbyshire, Janeth
PUB. DATE
October 1990
SOURCE
BMJ: British Medical Journal (International Edition);10/13/90, Vol. 301 Issue 6756, p825
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Assesses the efficacy of zidovudine in the treatment of early onset of HIV in Great Britain. Risk markers for HIV infections; Progression rate of HIV to AIDS; Development of severe anemia.
ACCESSION #
5061473

Tags: HIV (Viruses) -- Treatment;  AZT (Drug)

 

Related Articles

  • Zidovudine resistant HIV. Jeffries, D.J. // BMJ: British Medical Journal (International Edition);4/29/89, Vol. 298 Issue 6681, p1132 

    Examines efficacy of the nucleoside analogue 3'-azido-3'-deoxythymidine (zidovudine, AZT) on HIV treatment. Suppression of virus replication following treatment; Decrease on sensitivity of viral isolates among patients; Correlation between sensitivity testing and plasma concentration of zidovudine.

  • Effect of Race and/or Ethnicity in Use of Antiretrovirals and Prophylaxis for Opportunistic Infection: A Review of the Literature. Palacio, Herminia; Kahn, James G.; Richards, T. Anne; Morin, Stephen F. // Public Health Reports;May/Jun2002, Vol. 117 Issue 3, p233 

    Investigates potential associations between race or ethnicity and use of HIV-related medications in the U.S. Information on the antiretroviral drug zidovudine; Details on the HIV-related treatment guidelines; Overall range of use of antiretroviral agents.

  • The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection. Fisehl, Margaret A.; Richman, Douglas D.; Hansen, Nellie; Collier, Ann C.; Carey, John T.; Para, Michael F.; Hardy, W. David; Dolin, Raphael; Powderly, William G.; Allan, J. Davis; Wong, Brian; Merigan, Thomas C.; McAuliffe, Vincent J.; Hyslop, Newton F.; Rhame, Frank S.; Balfour, Henry H.; Spector, Stephen A.; Volberding, Paul; Pettinelli, Carla // Annals of Internal Medicine;5/15/90, Vol. 112 Issue 10, p727 

    Details the preliminary findings regarding the efficacy and safety of zidovudine in the treatment of HIV type 1 infection. Background on zidovudine; Adverse effects of zidovudine and placebo on the treatment group; Common reason for AIDS-disease progression.

  • Criticisms of Concorde dominate AIDS conference. Roberts, John // BMJ: British Medical Journal (International Edition);6/19/93, Vol. 306 Issue 6893, p1631 

    Assesses the efficacy of zidovudine for the treatment of HIV in Great Britain. Influence of the drug in the daily onset of AIDS; Increase in the CD4 counts of patients; Adverse effects of zidovudine.

  • Antiretroviral treatment to prevent mother-to-child transmission of HIV-1. McIntyre, J.; Gray, G. // South African Journal of Science;Jun2000, Vol. 96 Issue 6, p277 

    No abstract available.

  • Zidovudine for Thrombocytopenic Purpura Related to Human Immunodeficiency Virus (HIV) Infection. Oksenhendler, Eric; Bierling, Philippe; Ferchal, Francoise; Clauvel, Jean-Pierre; Seligmann, Maxime // Annals of Internal Medicine;3/1/89, Vol. 110 Issue 5, p365 

    Presents a study which examined the efficacy of zidovudine in increasing the platelet count of patients with thrombocytopenic purpura associated with HIV virus. Factors which contributed to the need for an alternative therapeutic treatment of thrombocytopenic purpura; Details of the clinical...

  • PWA's head south for AZT. Popert, Ken // Body Politic;Nov86, Issue 132, p15 

    Reports on the migration of some Canadian persons with AIDS (PWA) to the U.S. to acquire azidothymidine (AZT), a drug that is proved to be effective against HIV. Findings of a U.S. study of AZT conducted by Burroughs Wellcome Co.; Criteria that had to be met by Canadian PWA in order to avail...

  • SAFE AND SOUND UNDERGROUND. Gerhard, Susan // Mothering;Sep/Oct2001, Issue 108, p42 

    Focuses on the medical practice of prescribing azidothymidine (AZT) for children of HIV-positive mothers. Ways adopted by HIV-positive parents to avoid AZT administration; Negative effects of AZT on children's health; Reasons for questioning the existing therapy for HIV viruses.

  • POISONING OUR BABIES. Hodgkinson, Neville // Mothering;Sep/Oct2001, Issue 108, p66 

    Reports on the lethal dangers of the antiviral drug AZT, given to HIV-positive mothers in pregnancy and to their newborn babies. Basis for the AZT treatment strategy; Proven toxicities of the drug; Likelihood of rapid disease progression in babies born to mothers treated with the AZT drug.

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics